Targeted treatment and survival in advanced non-squamous non-small cell lung cancer patients – a nationwide and longitudinal study

Targeted treatment and survival in advanced non-squamous non-small cell lung cancer patients – a nationwide and longitudinal study

ObjectivesWe aimed to describe treatment patterns, time on treatment (ToT) and overall survival (OS) for patients with advanced non-squamous, EGFR+, ALK+ and ROS1+ NSCLC in Norway.Materials and methodsWe extracted data on patients ≥ 18 years diagnosed with advanced non-squamous NSCLC between 2015 an...

Full description

Saved in:
Bibliographic Details
Main Authors: Johanne Elise Nyen, Anja Ødegård Booth, Øyvind Husby, Christoffer Bugge, Ingrid Engebretsen, Francisco Oteiza, Åslaug Helland, Lars Fjellbirkeland, Odd Terje Brustugun, Bjørn Henning Grønberg
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-02-01
Series:Frontiers in Oncology
Subjects:
ROS
ALK
EGFR
real world data
lung cancer
time on treatment
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2025.1506041/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2025.1506041/full

Similar Items